- Home
- MUX vs CELC Comparison
MUX vs CELC Comparison
Compare MUX & CELC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MUX
- CELC
- Stock Information
- Founded
- MUX 1979
- CELC 2011
- Country
- MUX Canada
- CELC United States
- Employees
- MUX N/A
- CELC N/A
- Industry
- MUX Precious Metals
- CELC Medical Specialities
- Sector
- MUX Basic Materials
- CELC Health Care
- Exchange
- MUX Nasdaq
- CELC Nasdaq
- Market Cap
- MUX 501.8M
- CELC 594.7M
- IPO Year
- MUX N/A
- CELC 2017
- Fundamental
- Price
- MUX $8.53
- CELC $12.73
- Analyst Decision
- MUX Strong Buy
- CELC Strong Buy
- Analyst Count
- MUX 2
- CELC 6
- Target Price
- MUX $15.63
- CELC $29.17
- AVG Volume (30 Days)
- MUX 694.0K
- CELC 272.6K
- Earning Date
- MUX 11-05-2024
- CELC 11-14-2024
- Dividend Yield
- MUX N/A
- CELC N/A
- EPS Growth
- MUX N/A
- CELC N/A
- EPS
- MUX 2.07
- CELC N/A
- Revenue
- MUX $199,634,000.00
- CELC N/A
- Revenue This Year
- MUX $40.79
- CELC N/A
- Revenue Next Year
- MUX $2.75
- CELC N/A
- P/E Ratio
- MUX $4.11
- CELC N/A
- Revenue Growth
- MUX 47.02
- CELC N/A
- 52 Week Low
- MUX $5.92
- CELC $11.51
- 52 Week High
- MUX $12.50
- CELC $22.19
- Technical
- Relative Strength Index (RSI)
- MUX 39.53
- CELC 31.22
- Support Level
- MUX $8.00
- CELC $12.08
- Resistance Level
- MUX $8.92
- CELC $13.00
- Average True Range (ATR)
- MUX 0.44
- CELC 0.94
- MACD
- MUX -0.04
- CELC -0.32
- Stochastic Oscillator
- MUX 31.18
- CELC 24.24
About MUX McEwen Mining Inc.
McEwen Mining Inc is a mining and minerals production and exploration company focused on precious and base minerals in Argentina, Mexico, and the United States. The company's overall revenue is principally derived from the production of gold and silver. The company owns and operates the wholly-owned El Gallo 1 mine in Mexico, and has a minority shareholding in the company that operates the San Jose mine in Argentina. More than half the company's gold output is produced by the El Gallo 1 mine. The remaining gold production, and the majority of silver production, is produced by the San Jose mine. Geographically, the majority is from Canada.
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.